United States · Growth startup

Who invested in Clovis Oncology

4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$502Mraised across 4 rounds since 2009, from 4 sources

$145MGrowth$145MSeries A$20MRound$192MGrowth
Latest round
Growth, $192MNov 2013
Step-upi
9.6×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2010201120122013
$145MGrowth$145MSeries A$20MRound$192MGrowth
First round
Growth, $145M
May 2009
Biggest round
$192M
Growth · Nov 2013
Usual gap between rounds
2.5 years
the median of 2

The rounds

  1. Nov 2013
    Growth$192M

    No investor was named in the report.

    Reported by sec.govSEC filing: $192M sold, first sale Nov 2013

  2. Jun 2011
    Round$20M

    No investor was named in the report.

    Reported by sec.govSEC filing: $20M sold, first sale May 2011

  3. May 2009
    Growth$145M7 new

    From a historical funding recordSEC filing: $146M sold, first sale May 2009

  4. May 2009
    Series A$145M7 returning

    Reported by onbiovc.comSEC filing: $146M sold, first sale May 2009

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Growth2009Series A2009Round2011Growth2013New Enterprise AssociatesVersant VenturesDomain AssociatesFrazier Healthcare PartnersAbingworthAberdare VenturesProQuest Investments

The exit

ExitListingPriceWhen
IPONASDAQ:CLVS$130MNov 2011

From historical deal records. Wrong? Tell us.

Everyone who backed them

New Enterprise AssociatesVC firm2rounds
Versant VenturesVC firm2rounds
Domain AssociatesVC firm2rounds
Frazier Healthcare PartnersPrivate equity2rounds
AbingworthVC firm2rounds
Aberdare VenturesVC firm2rounds
ProQuest InvestmentsVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Clovis Oncology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site

Quick answers about Clovis Oncology

Who invested in Clovis Oncology?

Clovis Oncology's investors include New Enterprise Associates, Versant Ventures, Domain Associates, Frazier Healthcare Partners and Abingworth, and 2 more on record.

How much has Clovis Oncology raised?

Clovis Oncology has raised $502M across 4 rounds since 2009.

When did Clovis Oncology last raise?

Clovis Oncology's most recent round was a Growth of $192M in Nov 2013.

What was Clovis Oncology's biggest round?

Its most recent round, $192M in Nov 2013, is also its largest on record.

Who backed Clovis Oncology first?

Clovis Oncology's first round on record, in May 2009, was backed by New Enterprise Associates, Versant Ventures and Domain Associates and 4 others.

What stage is Clovis Oncology at?

Clovis Oncology's latest named round is a Growth, in Nov 2013.

Where is Clovis Oncology based?

Clovis Oncology is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app